The mRNA Foundation is guided by a Board of Directors comprised of leading industry voices. Get to know our board members and learn why each one of them is passionate about supporting the Foundation’s work.
“I lead the Foundation’s board because I am passionate about promoting public scientific literacy and recognize the need for workforce education in mRNA medicines, which are transforming healthcare through delivering innovative solutions to prevent and treat some of the most devasting diseases, ultimately improving or saving patients’ lives.”
Deborah Day Barbara
Chair, Board of Directors, Foundation for mRNA Medicines
Former VP, Strategy and Business Development, Maravai Life Sciences
“In addition to driving the next-generation of technology innovations for the mRNA field, Maravai believes that outreach within our communities and society as a whole is critical to ensuring that the power of mRNA medicines can be appreciated by all. As such, it is my honor to serve on the board for the AMM Foundation to offer my services to support this critical mission.”
Kate Broderick, PhD
Chief Innovation Officer
Maravai Life Sciences
“I’m proud to serve on the foundation board, working to provide accurate and trustworthy information on mRNA.”
Lena Ceballos
Manager, Corporate Communications & Marketing
Arcturus Therapeutics
“It is my privilege to serve on the Board of the Foundation for mRNA Medicines. Throughout my career, I have dedicated myself to advancing our understanding of mRNA science. I am deeply moved to see how this fundamental research has transformed into breakthrough therapies that are saving lives and enhancing human health worldwide. Through both my continued laboratory research and the Foundation’s vital outreach efforts, I remain committed to supporting and advancing this remarkable technology.”
Jeff Coller, Ph.D.
Bloomberg Distinguished Professor of RNA Biology and Therapeutics
Johns Hopkins University
“I am thrilled to serve on the foundation board as I believe mRNA will lead to new therapeutics and vaccines capable of addressing unmet clinical needs.”
Cynthia (Cindy) Collins
Board Member, Nutcracker Therapeutics
Former CEO, Editas Medicine
“Joining the Foundation board represents a unique opportunity for me to continue supporting efforts to educate the public about important scientific advances that will benefit society at-large and continuing to combat the misinformation that unfortunately is often associated with scientific progress.”
Erica Jefferson
Senior Vice President, Corporate Affairs
ReCode
“I am committed to advancing mRNA as a transformative modality for cell and gene therapies.”
Chris Mason, MD, PhD
Professor of Cell & Gene Therapy
University College London
“I’m excited to serve on the AMM Foundation board to help dispel myths surrounding mRNA vaccines.”
Baley Reeves, PhD
Director, National Center for Therapeutics Manufacturing
Texas A&M Engineering Experiment Station
“I joined the mRNA Foundation to help drive the advancement of a groundbreaking field with the potential to revolutionize medicine. By supporting the development of new mRNA-based therapies, we can create life-saving treatments that address unmet medical needs and bring hope to patients around the world.”
Claudia Zylberberg, PhD
Founder and Chair of the Board
Kosten Digital